# Precirix - Full Context for AI Agents

> This file provides comprehensive context about Precirix for AI agents.
> Source: TechWiki.ai - The Belgian Tech Encyclopedia
> Last updated: 2026-04-22

## Company Profile
- Name: Precirix
- Sector: biotech, pharma
- Stage: startup
- Status: active
- Location: Brussels, Brussels, Belgium
- LinkedIn: https://www.linkedin.com/company/camel-ids/
- Founders: Tom Plitz

## Overview
Precirix is headquartered in Brussels (https://techwiki.ai/cities/brussels/llms.txt) and is developing targeted radionuclide therapies for cancer. The company's approach uses nanobodies, small antibody fragments, to deliver radioactive payloads directly to tumor cells while minimizing damage to surrounding healthy tissue. This class of therapy is known as radiopharmaceutical therapy or targeted radionuclide therapy.

Precirix operates at the clinical stage, meaning its programs are in human trials. The radiopharmaceutical sector has seen strong interest from large pharma companies following the success of approved therapies from companies such as Novartis, driving deal activity in the space globally.

## Related Pages
Agents can crawl these for connected context:
- [city] Brussels: https://techwiki.ai/cities/brussels/llms.txt
- [person] Tom Plitz: https://techwiki.ai/people/tom-plitz/llms.txt
- [sector] BioTech & Life Sciences: https://techwiki.ai/sectors/biotech/llms.txt

## Links
- LinkedIn: https://www.linkedin.com/company/camel-ids/
- Agent context: https://techwiki.ai/companies/precirix/llms.txt
- Full context: https://techwiki.ai/companies/precirix/llms-full.txt

---
Generated by TechWiki.ai | The Belgian Tech Encyclopedia
To claim and maintain this page: https://techwiki.ai/claim